MedPath

Effect of Esmolol on Perioperative Stress Reaction

Phase 4
Not yet recruiting
Conditions
Stress Reaction
Airway Obstruction
Catecholamine; Overproduction
Esmolol
Interventions
Drug: saline
Registration Number
NCT05694585
Lead Sponsor
Xiumei Song
Brief Summary

The goal of this clinical trial is to observe the effect of low dose continuous infusion of esmolol on perioperative stress response in patients undergoing airway intervention .

Detailed Description

Airway intervention is known to activate stress response and release catecholamines resulting in severe hemodynamic instability. Various techniques which are recommended to prevent the stress response include increasing the depth of anesthesia, improving surgical procedures and the use of various pharmacological agents. Esmolol blocks the action of the endogenous catecholamines, we plan low dose esmolol infusion decrease stress response and hemodynamic fluctuation during airway intervention.

46 patients scheduled airway intervention under general anesthesia were randomly divided into esmolol group and control group. esmolol 50μg/kg/min or saline 50μg/kg/min were iv administered before Operation beginning. If HR(heart rate)is greater than 90 beats/min, esmolol or saline 50μg/kg/min is added each time, with interval more than 5 min and the peak value is 200 μg/kg/min. If the heart rate is lower than 60 times/minute, Stop medication. Plasma level of Norepinephrine, epinephrine, and cortisol before induction of anesthesia and 30 minutes after beginning of operation were determined by high-performance liquid chromatography. Perioperative hemodynamics changes, extubation time, incidence of severe sinus bradycardia and bronchospasm were recorded.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
46
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
esmolol groupEsmololesmolol group: esmolol 50 μg/kg /min were intravenously administered before Operation beginning. If HR(heart rate)is greater than 90 beats/min, esmolol 50μg/kg /min is added each time, with interval more than 5 min and the peak value is 200 μg/kg/min. If the heart rate is lower than 60 times/minute, Stop medication.
Saline solutionsalineSaline group: saline 50 μg/kg /min were intravenously administered before Operation beginning. If HR(heart rate)is greater than 90 beats/min, saline 50μg/kg /min is added each time, with interval more than 5 min and the peak value is 200 μg/kg/min. If the heart rate is lower than 60 times/minute, Stop medication.
Primary Outcome Measures
NameTimeMethod
Changes in plasma norepinephrine levelsup to 30 minutes after beginning of operation

level of Norepinephrine

Changes in plasma cortisol levelsup to 30 minutes after beginning of operation

level of cortisol

Changes in plasma epinephrine levelsup to 30 minutes after beginning of operation

level of epinephrine

Secondary Outcome Measures
NameTimeMethod
Hemodynamic changes :Heart rate(HR)from anesthesia induction to 30 minutes after remove the laryngeal mask

Heart rate(HR) during perioperative period

Laryngeal mask airway (LMA) removal timeDuration from the end of anesthetics infusion to LMA removal

Duration from the end of anesthetics infusion to LMA removal

Hemodynamic changes :Diastolic blood pressure( DBP)from anesthesia induction to 30 minutes after remove the laryngeal mask

Diastolic blood pressure( DBP) during perioperative period

Hemodynamic changes :Systolic blood pressure(SBP )from anesthesia induction to 30 minutes after remove the laryngeal mask

Systolic blood pressure (SBP ) during perioperative period

Incidence of adverse reactions: Severe sinus bradycardiafrom anesthesia induction to 30 minutes after remove the laryngeal mask

Severe sinus bradycardia: HR\<40 times/min during perioperative period

Incidence of adverse reactions: bronchospasmfrom anesthesia induction to 30 minutes after remove the laryngeal mask

Perioperative bronchospasm

© Copyright 2025. All Rights Reserved by MedPath